quant Mutual FundEquity Scheme - Large & Mid Cap Fund13.8 years
The scheme seeks to provide capital appreciation by investing in a portfolio of Large and Midcap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Prefer peers first
The live read flags issues. Inspect same-category alternatives before buying.
In three lines
Watch if · Maximum drawdown exceeded 35%.
Watch if · Risk metrics are withheld because the NAV history contains an implausible daily move above 50%.
Prefer peers if · Prefer Motilal Oswal Large and Midcap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Fail
The live read flags issues. Inspect same-category alternatives before buying.
Expense ratio
Pass
1.25% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -45.7%. Ask whether you can hold through a similar fall.
Vs category
Pass
81% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Sameer Kate · 1.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 80.8% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 46%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Review does not mean stop the SIP tomorrow - compare peers first. Stopping on a red label often locks in the worst path.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
27 May 2015 – 17 Nov 2020
Trough 29 Feb 2016 · recovered in 1723 days
-45.7%
27 Sept 2024 – open
Trough 4 Mar 2025 · not recovered
-24.1%
9 Jan 2013 – 28 Mar 2014
Trough 28 Aug 2013 · recovered in 212 days
-21.3%
11 Apr 2022 – 7 Sept 2022
Trough 20 Jun 2022 · recovered in 79 days
-17.5%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
88
Vs category
100
Consistency
69
Risk-adjusted
n/a
Drawdown
0
Mean
64
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Prefer peers first
The live read flags issues. Inspect same-category alternatives before buying.
Why this status
Supporting reads
Risk metrics are withheld because the NAV history contains an implausible daily move above 50%.
30 Sept 2026 · 33 holdings · top 10 are 80.8%.
Repo
Unspecified
21.9%
Aurobindo Pharma Ltd
Healthcare
9.8%
Lloyds Metals and Energy Ltd
Materials
9.7%
Samvardhana Motherson International Ltd
Consumer Discretionary
8.0%
Adani Enterprises Ltd
Materials
6.7%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Motilal Oswal Mutual Fund
Baroda BNP Paribas Mutual Fund
Caveat: Lower trailing returns
Edelweiss Mutual Fund
Caveat: Lower trailing returns
Bandhan Mutual Fund
DSP Mutual Fund
Caveat: Lower trailing returns
quant Mutual FundEquity Scheme - Large & Mid Cap Fund13.8 years
The scheme seeks to provide capital appreciation by investing in a portfolio of Large and Midcap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Prefer peers first
The live read flags issues. Inspect same-category alternatives before buying.
In three lines
Watch if · Maximum drawdown exceeded 35%.
Watch if · Risk metrics are withheld because the NAV history contains an implausible daily move above 50%.
Prefer peers if · Prefer Motilal Oswal Large and Midcap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Fail
The live read flags issues. Inspect same-category alternatives before buying.
Expense ratio
Pass
1.25% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Watch
Peak-to-trough -45.7%. Ask whether you can hold through a similar fall.
Vs category
Pass
81% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Sameer Kate · 1.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 80.8% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 46%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Review does not mean stop the SIP tomorrow - compare peers first. Stopping on a red label often locks in the worst path.
NAV
29 Oct 2026 · +4.5% over 1Y
133.685
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-6.6%
27 May 2015 – 17 Nov 2020
Trough 29 Feb 2016 · recovered in 1723 days
-45.7%
27 Sept 2024 – open
Trough 4 Mar 2025 · not recovered
-24.1%
9 Jan 2013 – 28 Mar 2014
Trough 28 Aug 2013 · recovered in 212 days
-21.3%
11 Apr 2022 – 7 Sept 2022
Trough 20 Jun 2022 · recovered in 79 days
-17.5%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
88
Vs category
100
Consistency
69
Risk-adjusted
n/a
Drawdown
0
Mean
64
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Prefer peers first
The live read flags issues. Inspect same-category alternatives before buying.
Why this status
Supporting reads
Risk metrics are withheld because the NAV history contains an implausible daily move above 50%.
30 Sept 2026 · 33 holdings · top 10 are 80.8%.
Repo
Unspecified
21.9%
Aurobindo Pharma Ltd
Healthcare
9.8%
Lloyds Metals and Energy Ltd
Materials
9.7%
Samvardhana Motherson International Ltd
Consumer Discretionary
8.0%
Adani Enterprises Ltd
Materials
6.7%